Logo image of NYT

NEW YORK TIMES CO-A (NYT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:NYT - US6501111073 - Common Stock

64.63 USD
+0.78 (+1.22%)
Last: 11/25/2025, 2:10:08 PM
Fundamental Rating

7

Taking everything into account, NYT scores 7 out of 10 in our fundamental rating. NYT was compared to 96 industry peers in the Media industry. NYT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NYT has a decent growth rate and is not valued too expensively. This makes NYT very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

NYT had positive earnings in the past year.
NYT had a positive operating cash flow in the past year.
Each year in the past 5 years NYT has been profitable.
Each year in the past 5 years NYT had a positive operating cash flow.
NYT Yearly Net Income VS EBIT VS OCF VS FCFNYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

NYT has a better Return On Assets (11.70%) than 93.75% of its industry peers.
NYT has a Return On Equity of 17.06%. This is amongst the best in the industry. NYT outperforms 87.50% of its industry peers.
NYT's Return On Invested Capital of 14.98% is amongst the best of the industry. NYT outperforms 94.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NYT is above the industry average of 8.15%.
The 3 year average ROIC (11.43%) for NYT is below the current ROIC(14.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.7%
ROE 17.06%
ROIC 14.98%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
NYT Yearly ROA, ROE, ROICNYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 12.29%, NYT belongs to the top of the industry, outperforming 85.42% of the companies in the same industry.
In the last couple of years the Profit Margin of NYT has grown nicely.
NYT has a Operating Margin of 16.12%. This is amongst the best in the industry. NYT outperforms 82.29% of its industry peers.
NYT's Operating Margin has improved in the last couple of years.
NYT has a Gross Margin (50.51%) which is in line with its industry peers.
NYT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.12%
PM (TTM) 12.29%
GM 50.51%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
NYT Yearly Profit, Operating, Gross MarginsNYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

NYT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for NYT has been reduced compared to 1 year ago.
Compared to 5 years ago, NYT has less shares outstanding
There is no outstanding debt for NYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NYT Yearly Shares OutstandingNYT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NYT Yearly Total Debt VS Total AssetsNYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 9.66 indicates that NYT is not in any danger for bankruptcy at the moment.
NYT's Altman-Z score of 9.66 is amongst the best of the industry. NYT outperforms 93.75% of its industry peers.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.66
ROIC/WACC1.72
WACC8.7%
NYT Yearly LT Debt VS Equity VS FCFNYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

NYT has a Current Ratio of 1.52. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
NYT has a better Current ratio (1.52) than 63.54% of its industry peers.
NYT has a Quick Ratio of 1.52. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
NYT has a Quick ratio of 1.52. This is in the better half of the industry: NYT outperforms 64.58% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.52
NYT Yearly Current Assets VS Current LiabilitesNYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.61% over the past year.
NYT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.92% yearly.
The Revenue has grown by 8.43% in the past year. This is quite good.
NYT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.37% yearly.
EPS 1Y (TTM)24.61%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%31.11%
Revenue 1Y (TTM)8.43%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.47%

3.2 Future

The Earnings Per Share is expected to grow by 13.13% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.49% on average over the next years.
EPS Next Y18.96%
EPS Next 2Y12.82%
EPS Next 3Y12.43%
EPS Next 5Y13.13%
Revenue Next Year7.96%
Revenue Next 2Y7.12%
Revenue Next 3Y6.63%
Revenue Next 5Y6.49%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NYT Yearly Revenue VS EstimatesNYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NYT Yearly EPS VS EstimatesNYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.16 indicates a quite expensive valuation of NYT.
Based on the Price/Earnings ratio, NYT is valued a bit cheaper than the industry average as 65.63% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 25.65, NYT is valued at the same level.
The Price/Forward Earnings ratio is 25.26, which means the current valuation is very expensive for NYT.
NYT's Price/Forward Earnings ratio is in line with the industry average.
NYT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.45, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.16
Fwd PE 25.26
NYT Price Earnings VS Forward Price EarningsNYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NYT.
NYT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 19.61
EV/EBITDA 17.81
NYT Per share dataNYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
NYT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as NYT's earnings are expected to grow with 12.43% in the coming years.
PEG (NY)1.43
PEG (5Y)1.61
EPS Next 2Y12.82%
EPS Next 3Y12.43%

6

5. Dividend

5.1 Amount

NYT has a Yearly Dividend Yield of 1.13%.
NYT's Dividend Yield is a higher than the industry average which is at 4.66.
With a Dividend Yield of 1.13, NYT pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.13%

5.2 History

The dividend of NYT is nicely growing with an annual growth rate of 21.48%!
NYT has been paying a dividend for at least 10 years, so it has a reliable track record.
NYT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)21.48%
Div Incr Years6
Div Non Decr Years11
NYT Yearly Dividends per shareNYT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

30.32% of the earnings are spent on dividend by NYT. This is a low number and sustainable payout ratio.
NYT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.32%
EPS Next 2Y12.82%
EPS Next 3Y12.43%
NYT Yearly Income VS Free CF VS DividendNYT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NYT Dividend Payout.NYT Dividend Payout, showing the Payout Ratio.NYT Dividend Payout.PayoutRetained Earnings

NEW YORK TIMES CO-A

NYSE:NYT (11/25/2025, 2:10:08 PM)

64.63

+0.78 (+1.22%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners98.63%
Inst Owner Change0.93%
Ins Owners0.61%
Ins Owner Change-0.63%
Market Cap10.52B
Revenue(TTM)2.75B
Net Income(TTM)337.87M
Analysts75
Price Target65.3 (1.04%)
Short Float %5.91%
Short Ratio5.65
Dividend
Industry RankSector Rank
Dividend Yield 1.13%
Yearly Dividend0.5
Dividend Growth(5Y)21.48%
DP30.32%
Div Incr Years6
Div Non Decr Years11
Ex-Date10-08 2025-10-08 (0.18)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.75%
Min EPS beat(2)9.76%
Max EPS beat(2)15.73%
EPS beat(4)4
Avg EPS beat(4)12.53%
Min EPS beat(4)6.49%
Max EPS beat(4)18.14%
EPS beat(8)8
Avg EPS beat(8)17.8%
EPS beat(12)12
Avg EPS beat(12)24.39%
EPS beat(16)16
Avg EPS beat(16)25.39%
Revenue beat(2)2
Avg Revenue beat(2)0.87%
Min Revenue beat(2)0.49%
Max Revenue beat(2)1.24%
Revenue beat(4)2
Avg Revenue beat(4)-0.02%
Min Revenue beat(4)-0.99%
Max Revenue beat(4)1.24%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)6
Avg Revenue beat(16)-0.37%
PT rev (1m)11.46%
PT rev (3m)7.31%
EPS NQ rev (1m)2.06%
EPS NQ rev (3m)4.26%
EPS NY rev (1m)0%
EPS NY rev (3m)1.78%
Revenue NQ rev (1m)1.58%
Revenue NQ rev (3m)2.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 27.16
Fwd PE 25.26
P/S 3.83
P/FCF 19.61
P/OCF 18.4
P/B 5.31
P/tB 7.88
EV/EBITDA 17.81
EPS(TTM)2.38
EY3.68%
EPS(NY)2.56
Fwd EY3.96%
FCF(TTM)3.3
FCFY5.1%
OCF(TTM)3.51
OCFY5.44%
SpS16.89
BVpS12.16
TBVpS8.2
PEG (NY)1.43
PEG (5Y)1.61
Graham Number25.52
Profitability
Industry RankSector Rank
ROA 11.7%
ROE 17.06%
ROCE 19.51%
ROIC 14.98%
ROICexc 20.57%
ROICexgc 33.73%
OM 16.12%
PM (TTM) 12.29%
GM 50.51%
FCFM 19.52%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
ROICexc(3y)14.65%
ROICexc(5y)14.2%
ROICexgc(3y)25.48%
ROICexgc(5y)21.57%
ROCE(3y)14.89%
ROCE(5y)13.67%
ROICexgc growth 3Y17%
ROICexgc growth 5Y17.39%
ROICexc growth 3Y3.36%
ROICexc growth 5Y8.52%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
F-Score9
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 41.68%
Cap/Sales 1.29%
Interest Coverage 250
Cash Conversion 108.27%
Profit Quality 158.8%
Current Ratio 1.52
Quick Ratio 1.52
Altman-Z 9.66
F-Score9
WACC8.7%
ROIC/WACC1.72
Cap/Depr(3y)35.41%
Cap/Depr(5y)44.4%
Cap/Sales(3y)1.22%
Cap/Sales(5y)1.45%
Profit Quality(3y)113.54%
Profit Quality(5y)142.07%
High Growth Momentum
Growth
EPS 1Y (TTM)24.61%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%31.11%
EPS Next Y18.96%
EPS Next 2Y12.82%
EPS Next 3Y12.43%
EPS Next 5Y13.13%
Revenue 1Y (TTM)8.43%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.47%
Revenue Next Year7.96%
Revenue Next 2Y7.12%
Revenue Next 3Y6.63%
Revenue Next 5Y6.49%
EBIT growth 1Y24.8%
EBIT growth 3Y10.95%
EBIT growth 5Y15.46%
EBIT Next Year37.56%
EBIT Next 3Y18.17%
EBIT Next 5YN/A
FCF growth 1Y103.17%
FCF growth 3Y17.6%
FCF growth 5Y21.42%
OCF growth 1Y97.41%
OCF growth 3Y15.12%
OCF growth 5Y16.67%

NEW YORK TIMES CO-A / NYT FAQ

What is the fundamental rating for NYT stock?

ChartMill assigns a fundamental rating of 7 / 10 to NYT.


Can you provide the valuation status for NEW YORK TIMES CO-A?

ChartMill assigns a valuation rating of 4 / 10 to NEW YORK TIMES CO-A (NYT). This can be considered as Fairly Valued.


What is the profitability of NYT stock?

NEW YORK TIMES CO-A (NYT) has a profitability rating of 8 / 10.


What are the PE and PB ratios of NEW YORK TIMES CO-A (NYT) stock?

The Price/Earnings (PE) ratio for NEW YORK TIMES CO-A (NYT) is 27.16 and the Price/Book (PB) ratio is 5.31.


How sustainable is the dividend of NEW YORK TIMES CO-A (NYT) stock?

The dividend rating of NEW YORK TIMES CO-A (NYT) is 6 / 10 and the dividend payout ratio is 30.32%.